Morpheus8 vs Microneedling: RF vs Needle-Only

Microneedling is the needle-only treatment: the American Academy of Dermatology (AAD) calls it a medical treatment that uses tiny needles to puncture the skin and stimulate collagen, which is why it is also called "collagen induction therapy".

Morpheus8 is a radiofrequency (RF) microneedling device.

In FDA's description of the technology, an array of microneedle electrodes penetrates the skin and each needle tip delivers a small area of intense heat at a set depth within or under the skin.

The regulatory footing is not symmetric.

FDA has authorized microneedling devices to improve the appearance of facial acne scars, facial wrinkles and abdominal scars in patients aged 22 or older.

Morpheus8's current 510(k) clearance, K231790, decided July 20, 2023, covers use "in dermatologic procedures where coagulation/contraction of soft tissue or hemostasis is needed" — the cleared text does not mention wrinkles, acne scars, skin tightening of the jowls, fat reduction or cellulite.

Both wordings matter when you read a treatment menu.

FDA's word for microneedling devices is "legally authorized"; for RF microneedling devices, Class II medical devices "cleared by the FDA through the 510(k) process".

The words to look for are cleared and authorized — not approved.

Where does SkinPen fit?

It is a needle-only device, and the first in the category that FDA authorized: the SkinPen Precision System was granted De Novo authorization DEN160029 on March 1, 2018, with a deliberately narrow indication — to improve the appearance of facial acne scars in adults aged 22 years or older — and is not intended for transdermal delivery of topical products such as cosmetics, drugs or biologics. "Morpheus8 vs SkinPen" is therefore the same comparison as RF versus needle-only, with brand names on it.

Needle-only microneedling is mechanical.

The needles puncture the skin, and the punctures are the treatment: the AAD's description is tiny needles puncturing skin to stimulate collagen.

FDA adds a framing note — microneedling may count as a medical procedure, not a cosmetic one, when the device is intended to change the structure or function of tissue.

Morpheus8 is mechanical plus thermal.

FDA describes RF microneedling as an array of microneedle electrodes, each producing a small area of intense heat at its tip, at a set depth within or under the skin.

So RF microneedling vs microneedling is not needles versus no needles — it is needles versus needles plus heat.

InMode's device family was first cleared under the Morpheus8 name in K192695, decided December 27, 2019.

Depth is where the hardware shows.

The 2019 clearance listed four single-use tips — 24-pin, 40-pin, 12-pin and a fixed 0.5 mm "T" tip — and the 2020 clearance, K200947, raised the 24- and 40-pin tips' maximum treatment depth from 4.0 mm to 7.0 mm, leaving the 12-pin tip at 4.0 mm.

Which tip and depth a practice plans to use is a fair question at booking.

InMode calls Morpheus8 "the first and only FDA cleared fractional radiofrequency device for soft tissue contraction" — that is the maker's claim, not an independent description.

The honest starting point: we found no head-to-head trial comparing Morpheus8 with needle-only microneedling in the research for this page, so this page cannot rank the two overall.

What follows is what each side's evidence says.

Needle-only microneedling holds FDA's appearance claims — the devices are authorized to improve the appearance of facial acne scars, facial wrinkles and abdominal scars in patients 22 or older.

For SkinPen, the pivotal study behind its authorization followed 41 adults with moderate-to-severe atrophic acne scars, 20 of them treated with the final device across three treatments about 30 days apart: at 6 months after the last treatment, 55% (11 of 20) of the treated group showed improvement on blinded photo grading, 45% showed no change, and none were graded worse.

The AAD also describes a wider microneedling use list — acne scars, dark spots, large pores, melasma, stretch marks, texture and fine lines — broader than the three indications FDA has authorized.

RF microneedling's evidence for this comparison is studies rather than an appearance claim: Morpheus8's cleared indication text names no wrinkle, acne-scar or skin-tightening outcome.

A 2021 review of 42 randomized, split-face or blinded studies concluded RF microneedling is effective and can be used in darker skin phototypes, with collagen remodeling that is slow and progressive and keeps improving even 6 months after treatment.

A 2026 systematic review of 20 studies and 558 participants found adverse events mostly mild and transient — erythema and swelling most common — with no serious complications in the included studies and pain typically mild to moderate; some of its authors work for or speak for RF device maker Jeisys.

Real-world reports are less tidy.

A 2026 analysis of FDA MAUDE reports from January 2013 to October 2025 found 114 RF microneedling reports with 224 events; the most frequent were textural changes (25.0%), pigment changes (18.3%) and fat loss (11.6%), followed by inflammatory reactions, burns (6.3%) and pain.

These are shares of reported events, not incidence rates.

Skin tone is a real fork in this comparison.

Every Morpheus8 clearance limits energy above 62 mJ per pin to Fitzpatrick types I-IV, so darker types V-VI are within labeling only at lower energies.

FDA flags a risk of skin darkening or lightening after microneedling in darker skin types; the SkinPen authorization study, by contrast, enrolled a diverse population — 11 of 41 subjects were Fitzpatrick type V or VI, and FDA says the study demonstrated the device on types II-VI.

For acne scars with platelet-rich plasma (PRP), the AAD says microneedling with PRP typically takes 3 to 5 treatments every 2 to 4 weeks and that studies found this plan can fade acne scars by 50% to 70%.

FDA's line on any such add-on is blunt: microneedling devices are not approved for delivering blood products such as PRP — or cosmetics, topical medications, vitamin solutions or drugs — into the skin.

Session counts run on series logic.

Cleveland Clinic's cosmetic center describes RF microneedling as done under topical numbing, taking about an hour, and typically involving two to four treatments, with results typically best three to six months after the first treatment.

FDA notes more than one microneedling session may be needed; the AAD says full results usually take several months and fade as collagen is lost, and that a yearly maintenance session may be recommended.

Recovery is described by different sources, and none in our research compares the two directly or gives a Morpheus8-specific recovery time.

Cleveland Clinic describes RF skin as usually mildly red for about 24 hours, with most people resuming normal routines within a day.

The AAD describes needle-only reactions — redness or darker shades on darker skin, a sunburn-like feeling, burning or swelling — that usually clear within a few days to a week, with an immediate return to work and a 24-hour wait before makeup.

FDA's common-risk list for microneedling runs from dryness, rough skin, tightness, redness, itching and peeling to discomfort, burning, bruising, bleeding and crusting, with pigment changes, lines on the face, cold-sore reactivation, swollen lymph nodes and infection listed as less common.

On price, our research holds no confirmed national figure for either treatment, so we will not invent one.

Insurance rarely covers elective cosmetic procedures such as RF microneedling, per Cleveland Clinic.

The one same-source price pair in our research is LaserAway's published menu, read October 16, 2026: Potenza RF microneedling for the face at $750 per treatment, or $562.50 each in a 6-pack, against SkinPen for the face at $400, or $300 each in a 6-pack.

Those are one chain's prices for two brands — not a Morpheus8 price, and not a national average.

Each side's pricing is broken down further on our Morpheus8 cost and microneedling cost pages.

We could not find a sourced schedule for combining the two — nothing in our research says whether RF and needle-only microneedling can share a session, which should go first, or how far apart they should sit.

Spacing and order are provider judgments, so ask any office that offers both how they sequence them and what the plan is based on.

What the sources do establish is smaller.

Both are medical procedures in FDA's framing — RF microneedling "is a medical procedure, not a cosmetic treatment", and microneedling may count as one when the device is intended to change the structure or function of tissue.

Multi-session plans appear in both descriptions: two to four treatments is the typical RF description, and FDA notes more than one microneedling session may be needed.

Add-ons are where combination plans meet the regulator.

Because microneedling devices are not approved for delivering cosmetics, topical medications, vitamin solutions, drugs or blood products such as PRP into the skin, a package that pushes a serum or PRP through the device is delivering those products in a way FDA has not approved.

The hygiene rule FDA states for microneedling devices is one more thing to ask about: re-using a cartridge is unsafe even if it is cleaned, and FDA advises asking whether a new one is opened for each patient and each session.

The research does not produce a winner, so we will not invent one.

What it produces is wording to match to your goal: needle-only microneedling devices carry FDA's appearance claims — facial acne scars, facial wrinkles, abdominal scars, age 22 and older — while Morpheus8's cleared text covers dermatologic procedures where coagulation/contraction of soft tissue or hemostasis is needed.

Which fits your skin is a question for a licensed provider who examines it.

Suitability rules apply to both.

FDA lists people for whom microneedling may not be suitable: anyone pregnant or breastfeeding, taking isotretinoin now or in the past 6 months, with a bleeding disorder or on blood thinners, immunosuppressed, with an active skin infection, a cold-sore outbreak, a keloid history, uncontrolled diabetes, or a current tan — plus a pigment-change risk it flags in darker skin types.

The AAD's version says at least one month must pass since the last isotretinoin pill and adds deep or pus-filled pimples and weakened immunity; FDA's 6-month window is the more conservative of the two.

Morpheus8 carries a labeling limit of its own: above 62 mJ per pin, its clearances cover Fitzpatrick types I-IV only, so darker types V-VI are within labeling at lower energies — a fair question if you have a darker skin type.

Before booking an RF treatment, FDA's advice is to seek a licensed health care provider with training and experience on the device and to ask which device will be used; the agency also says consumers can look up a device's cleared indication in its 510(k) database.

For needle-only microneedling, the AAD adds that at-home and non-medical-spa microneedling products are not meant to puncture the skin and give less noticeable results.

Prices and device menus are local — our research found no national figure for either treatment — so the useful comparison is the one you assemble.

For the detail on each side, start with our Morpheus8 guide and our microneedling guide.